Session Type
Meeting
Search Results for VTE
Abstract Number: 140
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Cachexia and anorexia occur in 50-80% of cancer patients. In cancer patients, it is associated with shorter survival, treatment failure, early treatment termination, declining functional status, and reduced quality of life. Megestrol acetate is a synthetic derivative of progesterone commonly used to treat cancer-related cachexia. Megestrol use is associated with thromboembolism among other adverse […]
Abstract Number: 144
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Venous thromboembolism (VTE) is a serious and all too frequent hospital complication, therefore assessing each patient’s individual risk of VTE is an important part of their care. Multiple models are available for risk assessment, however most not only include multiple data points requiring redundant entry, but can be labor intensive and time-consuming to complete on […]
Abstract Number: 147
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Venous thromboembolism (VTE) is a major cause of morbidity and mortality in the United States. The increased risk of VTE among medically ill older adults is firmly established. Guidelines strongly promote the use of pharmacologic VTE prophylaxis in this population, yet studies have suggested sub-optimal prophylaxis rates. Our study aimed to describe current provider […]
Abstract Number: 181
SHM Converge 2021
Background: Venous thromboembolism (VTE) is a significant cause of morbidity and mortality for hospitalized patients. There are approximately 900,000 new VTE events and 100,000 VTE-related deaths every year. In the United States, more deaths occur due to VTE than breast cancer, AIDS, and motor vehicle accidents combined. VTE are considered preventable events with appropriate prophylaxis; […]
Abstract Number: 182
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: Compared with patients in the community, patients acutely hospitalized are at higher risk of developing venous thromboembolism (VTE), contributing to patient morbidity and mortality and healthcare costs. The need for thromboprophylaxis for post-surgical patients is well-known and the importance of thromboprophylaxis for acutely-ill hospitalized medicine patients has been increasingly accepted. We aimed to analyze […]
Abstract Number: 182
SHM Converge 2021
Background: Venous thromboembolism (VTE) poses a significant risk to patients in the hospital setting, and studies have shown that VTE prophylaxis should be incorporated into the management of high-risk patients during their hospital stay. However, many of these patients are still high-risk for VTE at the time of discharge and for up to three months […]
Abstract Number: 185
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Choice of agent for venous thromboembolism prophylaxis (VTEP) after joint arthroplasty is a complex decision, the difficulty of which has been compounded by divergent guidelines. Specifically, the adequacy of aspirin monotherapy (ASA) for VTEP has long been debated between the American Academy of Orthopaedic Surgeons (AAOS) and the American College of Chest Physicians (ACCP). […]
Abstract Number: 203
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Venous Thromboembolism (VTE) is a potentially life-threatening disorder and in some cases, is related to underlying hypercoagulability which may be congenital or acquired. Guidelines suggest performing extensive work -up for hypercoagulability only in select patients: those with close family history of VTE at young age ( < 45), young age at first VTE (<45), […]
Abstract Number: 204
Hospital Medicine 2020, Virtual Competition
Background: Risk assessment for venous thromboembolism (VTE) is a part of every hospital admission. The workflow of who completes the assessment varies between hospitals, but often it is carried out by trainees. VTE risk assessment is further complicated by the variety of methods to identify those patients who are appropriate for chemoprophylaxis, mechanical prophylaxis, or […]
Abstract Number: 204
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Health information technology (HIT) has the potential to decrease rates of hospital-acquired conditions. The Patient Safety Learning Lab (PSLL) developed a suite of HIT tools to engage patients, families, and providers in identifying, assessing, and reducing patient safety threats. The goal of this current evaluation is to quantify the effects of this intervention on […]